UBS Group’s Lixte Biotechnology Holdings, Inc. Warrants LIXTW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-4,088
| Closed | -$245 | – | 8549 |
|
|
2024
Q2 | $245 | Buy |
4,088
+235
| +6% | +$14 | ﹤0.01% | 7871 |
|
|
2024
Q1 | $193 | Buy |
3,853
+3,643
| +1,735% | +$182 | ﹤0.01% | 7566 |
|
|
2023
Q4 | $8 | Buy |
+210
| New | +$8 | ﹤0.01% | 7913 |
|
|
2023
Q2 | – | Sell |
-811
| Closed | -$70 | – | 8149 |
|
|
2023
Q1 | $70 | Buy |
+811
| New | +$70 | ﹤0.01% | 8190 |
|
|
2022
Q4 | – | Sell |
-7,623
| Closed | – | – | 9685 |
|
|
2022
Q3 | $0 | Buy |
7,623
+90
| +1% | – | ﹤0.01% | 9478 |
|
|
2022
Q2 | $1K | Sell |
7,533
-1,067
| -12% | -$142 | ﹤0.01% | 8853 |
|
|
2022
Q1 | $2K | Buy |
8,600
+2,350
| +38% | +$547 | ﹤0.01% | 8585 |
|
|
2021
Q4 | $3K | Sell |
6,250
-2,274
| -27% | -$1.09K | ﹤0.01% | 8540 |
|
|
2021
Q3 | $5K | Sell |
8,524
-510
| -6% | -$299 | ﹤0.01% | 7392 |
|
|
2021
Q2 | $7K | Buy |
9,034
+1,855
| +26% | +$1.44K | ﹤0.01% | 7229 |
|
|
2021
Q1 | $6K | Sell |
7,179
-16,061
| -69% | -$13.4K | ﹤0.01% | 7202 |
|
|
2020
Q4 | $21K | Buy |
+23,240
| New | +$21K | ﹤0.01% | 5903 |
|